药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Econazole
Emibetuzumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Emibetuzumab.
Econazole
Dalotuzumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Dalotuzumab.
Econazole
Lampalizumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Lampalizumab.
Econazole
Tremelimumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Tremelimumab.
Econazole
Solanezumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Solanezumab.
Econazole
Onartuzumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Onartuzumab.
Econazole
Depatuxizumab mafodotin
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Depatuxizumab mafodotin.
Econazole
Bapineuzumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Bapineuzumab.
Econazole
Durvalumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Durvalumab.
Econazole
Figitumumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Figitumumab.
Econazole
Ficlatuzumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Ficlatuzumab.
Econazole
Tabalumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Tabalumab.
Econazole
Conatumumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Conatumumab.
Econazole
Human Varicella-Zoster Immune Globulin
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Human Varicella-Zoster Immune Globulin.
Econazole
Eftrenonacog alfa
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Eftrenonacog alfa.
Econazole
Tetanus Immune Globulin
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Tetanus Immune Globulin.
Econazole
Atezolizumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Atezolizumab.
Econazole
Necitumumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Necitumumab.
Econazole
Daratumumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Daratumumab.
Econazole
Evolocumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Evolocumab.